We hope you enjoy this edition of The Daffodil. It features just a few examples of the important work that your exceptional kindness makes possible.
Thanks to you, we are funding critical support services for the 30,000 Queenslanders who are diagnosed with cancer every year, while also looking towards the future and continuing to invest in lifesaving cancer research.
As we pass the halfway mark in Cancer Council Queensland’s 60th anniversary year, we reflect on the generosity of Queenslanders like yourself, who have always been the cornerstone of our journey towards a future free from cancer.Get the latest edition Make a donation
In this edition of The Daffodil, you can read about some incredible research projects your support is helping to fund through the Accelerating Collaborative Cancer Research (ACCR) grants scheme (page 4), and right here in our own Viertel Cancer Research Centre with the Australian Cancer Atlas (page 10). These critical projects demonstrate how Queensland researchers are making strides in improving cancer care and understanding the impact of cancer, not only in our own state, but across the globe.
We are also pleased to share with you, our plans for a new cancer support centre called Daffodil Place (page 6), in Rockhampton. Daffodil Place will be a community space where Queenslanders impacted by cancer, whether they be patients, carers, family, or friends, can find information and support and engage in activities to improve their general wellbeing. We plan on opening more of these support centres across Queensland in the years to come.
Progress is the key to longevity and success. In 2021, we are seizing new ideas to improve our services in support of Queenslanders impacted by cancer. You are a vital part of this mission.
Your support and generosity allows us to help thousands of Queenslanders impacted by cancer – thank you!
As the world moves online, the loved ones of those who have passed away from cancer have asked for a more convenient means of donating.
Ovarian cancer has the worst survival rates of all gynaecological cancers, with only 45% of those diagnosed living longer than 5 years.